About CKD OTTO Pharma
Specialized in Oncology Medicine
Established in 2015, PT CKD OTTO Pharmaceuticals (“CKD OTTO Pharma”) is a joint venture between Chong Kun Dang Pharm Corp., a leading pharmaceutical company in Korea, with PT Otto Pharmaceutical Industries, a member of Indonesian leading pharmaceutical company MENSA Group.
CKD OTTO Pharma specialization is anti-cancer drugs as known as oncology medicines in Indonesian market. We cooperate with many hospitals throughout Indonesia to provide the best quality of oncology medicines. Our aim in the future is not only to reach the domestic market, but also to expand our market to ASEAN, MENA and EU countries. Implementing the same mission "Better Life through Better Medicine" as our major shareholder in Korea, we are eager to grow to become the number one pharmaceutical company in Indonesia.